
Lexeo Therapeutics, a clinical-stage gene therapy company, has raised $85 million in Series A financing. Longitude Capital and Omega Funds led the round.
Source: Press Release
Lexeo Therapeutics, a clinical-stage gene therapy company, has raised $85 million in Series A financing.
Lexeo Therapeutics, a clinical-stage gene therapy company, has raised $85 million in Series A financing. Longitude Capital and Omega Funds led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination